Lyell Immunopharma, Inc.

LYELNasdaq· Pharmaceutical Preparations

Price History

Revenue

$36,000

▼ 41.0% YoY

Net Income

-$274.4M

▲ 20.0% YoY

EPS

$-16.06

▲ 38.8% YoY

Cash

$60.2M

▼ 43.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.